A prospective evaluation of novel early indicators of drug efficacy in patients with metastatic colorectal cancer using 18F-fluorodeoxyglucose positron-emission tomography, circulating tumor cells and the RECIST criteria
Invited conference paper presented and published in conference proceedings


全文

其它資訊
著者LI Leung, WONG Cesar, KING D Ann, LOONG Herbert Ho Fung, POON Annette, HO Wing Ming, HO Ngan Ling, MO Kwok Fai, CHAN Ming Lok, WANG Ki, CHAN Anthony Tak Cheung, MA Buig Yue Brigette
會議名稱The 19th Annual Scientific Symposium of The H.K. Cancer Institute, Frontiers in Early Drug Development in Oncology and Internal Medicine
會議開始日22.11.2014
會議國家/地區中國
會議論文集題名The 19th Annual Scientific Symposium of The H.K. Cancer Institute, Frontiers in Early Drug Development in Oncology and Internal Medicine
詳細描述organized by H.K. Cancer Institute & Dept. of Clinical Oncology in conjunction with Partner SKL of Oncology in South China, Phase I Clinical trial Cen
出版年份2014
月份11
日期22
出版地China, Hong Kong
語言英式英語
關鍵詞metastatic colorectal cancer; RECIST

上次更新時間 2018-24-01 於 15:45